<div id="readability-page-1"><p>Shares of OpGen, Inc. (OTC:OPGN - Get Free Report) crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $2.85 and traded as high as $10.90. OpGen shares last traded at $10.50, with a volume of 6,314 shares changing hands.</p><h2>OpGen Stock Performance</h2><p>The stock's 50-day moving average price is $2.85 and its two-hundred day moving average price is $3.53. The stock has a market capitalization of $105.75 million, a PE ratio of -1.89 and a beta of -1.77. </p><h2>About OpGen</h2> (Get Free Report)<p>OpGen, Inc, a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits.</p><h2>See Also</h2><ul><li>Five stocks we like better than OpGen</li><li>Why Understanding Call Option Volume is Essential to Successful Options Trading</li><li>Rocket Lab’s Big Rebound? Analysts Suggest the Dip's a Gift</li><li>Best Aerospace Stocks Investing </li><li>Meta’s AI Moment? New SAM 3 Model Has Wall Street Turning Bullish</li><li>How to Invest in the FAANG Stocks</li><li>Snowflake Stock: The Dip That Smart Investors Are Buying Right Now</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in OpGen Right Now?</h2><p>Before you consider OpGen, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and OpGen wasn't on the list.</p><p>While OpGen currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

OPGN

<p>OpGen's stock (OTC:OPGN) crossed above its 50-day moving average, trading as high as $10.90, with a last price of $10.50. The stock's 50-day average is $2.85, and its 200-day average is $3.53. Despite a Hold rating, analysts suggest better investment options than OpGen.</p>

OpGen (OTC:OPGN) Share Price Passes Above Fifty Day Moving Average - Should You Sell?